APP and Alzheimer disease: Moreover, AICD transgenic mice exhibit AD-like features, including abnormal phosphorylation of tau [41], and APP overexpression in neuronal cells, which resulted in axonopathies, was linked to activation of the MAPK pathway by AICD in a NPTY-motif-dependent manner [18,57].